日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CRISPR-Drug Combinatorial Screening Identifies Effective Combination Treatments for MTAP-Deleted Cancer

CRISPR药物组合筛选鉴定出MTAP缺失型癌症的有效联合疗法

Knoll, Nikola; Masser, Sarah; Bordas, Blanka; Ebright, Richard Y; Li, Guangyan; Kesar, Devishi; Destefanis, Eliana; Kania, Nicholas; Rodriguez, Diego J; Jen, Jayu; Zagar, Sydney E; Mensah, Caleb; Chen, Zixin; Moffitt, Samuel J; Enakireru, Erhumuoghene M; He, Yao; Feng, Baomou; Chokshi, Mira K; Jin, Cyrus Y; Raghavan, Srivatsan; Sellers, William R; Mulvaney, Kathleen M

Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo-angiogenesis to promote lung cancer progression

Kras/YY1/ZNF322A/Shh转录轴失调增强新生血管生成,从而促进肺癌进展

Lin, Che-Chung; Kuo, I-Ying; Wu, Li-Ting; Kuan, Wen-Hui; Liao, Sheng-You; Jen, Jayu; Yang, You-En; Tang, Cheng-Wei; Chen, Yi-Rong; Wang, Yi-Ching

SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models.

SHP2 抑制可防止多种癌症模型中对 MEK 抑制剂产生适应性耐药性

Fedele Carmine, Ran Hao, Diskin Brian, Wei Wei, Jen Jayu, Geer Mitchell J, Araki Kiyomi, Ozerdem Ugur, Simeone Diane M, Miller George, Neel Benjamin G, Tang Kwan Ho

Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression

Oct4通过转录调控长链非编码RNA NEAT1和MALAT1的表达,促进肺癌进展。

Jen, Jayu; Tang, Yen-An; Lu, Ying-Hung; Lin, Che-Chung; Lai, Wu-Wei; Wang, Yi-Ching

Zinc finger proteins in cancer progression

锌指蛋白在癌症进展中的作用

Jen, Jayu; Wang, Yi-Ching

A prognostic predictor panel with DNA methylation biomarkers for early-stage lung adenocarcinoma in Asian and Caucasian populations

针对亚洲和高加索人群早期肺腺癌的DNA甲基化生物标志物预后预测因子组合

Kuo, I-Ying; Jen, Jayu; Hsu, Lien-Huei; Hsu, Han-Shui; Lai, Wu-Wei; Wang, Yi-Ching